» Authors » Dabit Arzamendi

Dabit Arzamendi

Explore the profile of Dabit Arzamendi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 139
Citations 837
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Echarte-Morales J, Cepas-Guillen P, Arzamendi D, Monivas V, Carrasco-Chinchilla F, Pan M, et al.
Am J Cardiol . 2025 Feb; 243:50-58. PMID: 39984153
Recurrent tricuspid regurgitation (TR) following transcatheter edge-to-edge repair (TEER) has not been thoroughly investigated. We aimed to examine the predictive factors and mid-term outcomes of recurrent TR following successful TEER....
2.
Li C, Asmarats L, Masso van Roessel A, Capellades H, Millan X, Arzamendi D
Rev Esp Cardiol (Engl Ed) . 2025 Feb; PMID: 39938678
No abstract available.
3.
Li C, Asmarats L, Masso van Roessel A, Capellades H, Fernandez-Peregrina E, Arzamendi D
Rev Esp Cardiol (Engl Ed) . 2025 Feb; PMID: 39938677
No abstract available.
4.
Ruberti A, Cepas-Guillen P, Echarte-Morales J, Arzamendi D, Monivas V, Carrasco-Chinchilla F, et al.
Rev Esp Cardiol (Engl Ed) . 2025 Feb; PMID: 39894161
Introduction And Objectives: This study aimed to assess the effectiveness and clinical outcomes of tricuspid transcatheter edge-to-edge repair (T-TEER) in patients with cardiac implantable electronic devices (CIEDs). Methods: This subanalysis...
5.
Sisinni A, Barreiro-Perez M, Freixa X, Arzamendi D, Monivas V, Carrasco-Chinchilla F, et al.
J Am Heart Assoc . 2025 Jan; 14(2):e037070. PMID: 39818971
Background: Significant tricuspid regurgitation (TR) is associated with increased morbidity and mortality. The development of transcatheter valve repair therapies has opened a wide range of opportunities for treatment of patients...
6.
Haberman D, Estevez-Loureiro R, Czarnecki A, Melillo F, Adamo M, Villablanca P, et al.
Eur J Heart Fail . 2025 Jan; PMID: 39809715
Aims: To evaluate the association between transcatheter edge-to-edge repair (TEER) and outcomes in patients with significant mitral regurgitation (MR) following acute myocardial infarction (MI), focusing on the aetiology of acute...
7.
Rodes-Cabau J, Nombela-Franco L, Muntane-Carol G, Veiga G, Regueiro A, Nazif T, et al.
Heart Rhythm . 2024 Dec; PMID: 39694306
Background: There is a large variability in the management of conduction disturbances (CDs) after transcatheter aortic valve replacement (TAVR). Objective: This study aimed to validate a prespecified algorithm for managing...
8.
Garot P, Cepas-Guillen P, Flores-Umanzor E, Leduc N, Bajoras V, Perrin N, et al.
Rev Esp Cardiol (Engl Ed) . 2024 Dec; PMID: 39645198
Introduction And Objectives: The optimal antithrombotic therapy (AT) after left atrial appendage closure (LAAC) is debated. We assessed the impact of intensive vs nonintensive AT on the incidence of device-related...
9.
Guthoff H, Abdel-Wahab M, Kim W, Witberg G, Wienemann H, Thurow M, et al.
JACC Cardiovasc Interv . 2024 Nov; 17(22):2626-2635. PMID: 39603776
Background: Prosthesis-patient mismatch after transcatheter aortic valve replacement (TAVR) can be measured echocardiographically (measured prosthesis-patient mismatch [PPMm]) or predicted (predicted prosthesis-patient mismatch [PPMp]) using published effective orifice area (EOA) reference...
10.
Echarte-Morales J, Guerreiro C, Freixa X, Arzamendi D, Monivas V, Carrasco-Chinchilla F, et al.
JACC Cardiovasc Interv . 2024 Nov; 17(23):2764-2777. PMID: 39520435
Background: Procedural success following tricuspid transcatheter edge-to-edge repair (TEER) has been defined variably over time; however, the consequences of achieving a tricuspid regurgitation (TR) grade of 0/1+ are still unclear....